Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Edwards Lifesciences Corp (EW)

1K + Investors. Track Smart Money conviction in EW. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -20
Streak
1Q ▼
Buyers last Q
49%

Smart Money Signals — EW

Based on 1286 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds reduced or closed their EW positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
🏔️

At the ownership peak (98% of max)

98% of all-time peak
1,286 hedge funds hold EW right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
📶

Steady growth — +9% more funds vs a year ago

fund count last 6Q
+108 new funds entered over the past year (+9% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟠

More sellers than buyers — 49% buying

586 buying600 selling
Last quarter: 600 funds reduced or exited vs 586 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.
⚠️

Fewer new buyers each quarter (-70 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 173 → 123 → 190 → 120. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
🔒

70% of holders stayed for 2+ years

■ 70% conviction (2yr+) ■ 16% medium ■ 13% new
906 out of 1,286 hedge funds have held EW for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
➡️

Steady discovery — ~120 new funds/quarter

126 → 173 → 123 → 190 → 120 new funds/Q
New funds entering each quarter: 173 → 123 → 190 → 120. Consistent flow of new institutional buyers without clear acceleration or slowdown.
🏛️

Veteran-anchored — 73% veterans vs 16% newcomers

■ 73% veterans ■ 11% 1-2yr ■ 16% new
Entry-cohort mix of 1,328 holders: 974 (73%) are 2+ year veterans, 142 entered 1–2 years ago, and 212 (16%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
🏆

Elite ownership — 51% AUM from top-100 funds

51% from top-100 AUM funds
62 of 1279 holders are among the 100 largest funds by AUM, controlling 51% of total institutional value in EW. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
3.4
out of 10
Low Exit Risk
Exit risk score 3.4/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — EW

In 2026 Q1, 586 hedge funds were net buyers of EW (120 opened a new position, 466 added to an existing one), while 600 reduced or exited (460 trimmed, 140 sold completely) — a 49% buyer ratio, indicating roughly balanced activity. 51% of total institutional value in EW is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: -20 funds (more exits than new entries). Total institutional holders: 1286.

Hedge Fund Ownership: EW

How many hedge funds hold EW — quarterly history vs. share price
Quarterly hedge fund ownership of EW vs. share price

Market Analysis: EW

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: EW

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Edwards Lifesciences Corp (EW) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much EW has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 77d ago
EW
+7.7%
XLV
nan%

EW outperformed XLV by nan% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 32d ago
EW
+6.0%
XLV
nan%

Since the filing became public, EW outperformed XLV by nan% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Broad Consensus, Selective Conviction

Many quality funds hold this stock, but top-tier positions remain relatively small.

69 top-rated funds 6 high-conviction
Consensus
8.0
/ 10
breadth
×
Elite
3.5
/ 10
conviction
Hedge Fund Positioning: EW
1K + Investors

Track Smart Money conviction in EW. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 1273 1306 -2.53%
13F Shares 416M 512M -18.76%
Total Value $32.18B $43.11B -25.35%
New Positions 115 190 -75
Increased Positions 456 415 +41
Closed Positions 148 119 +29
Reduced Positions 444 467 -23
Total Calls 21 26 -19.23%
Total Puts 28 23 21.74%
PUT/CALL Ratio 1.33 0.88 Bearish

Statistics: EW

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

1K + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in EW. Verified SEC 13F-HR filings.

QUARTER:
Top 25 EW holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 2Xideas AG 11.05% 352,077 $28.2M
2 Seilern Investment Management Ltd 6.59% 690,191 $55.3M
3 Wormser Freres Gestion 5.25% 88,910 $7.3M
4 WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST 4.75% 4,800,000 $384.4M
5 Amiral Gestion 4.29% 96,389 $7.7M
6 Titan Wealth (CI) Ltd 3.52% 101,900 $8.2M
7 Wilson Asset Management (international) Pty Ltd 3.28% 144,918 $11.6M
8 Haven Capital Group, Inc. 3.27% 44,056 $3.5M
9 Triodos Investment Management BV 3.04% 501,858 $40.2M
10 Manitou Investment Management Ltd. 2.92% 184,195 $14.8M
11 Wedgewood Partners Inc 2.83% 170,969 $13.7M
12 Atle Fund Management AB 2.67% 106,518 $8.3M
13 Birch Hill Investment Advisors LLC 2.66% 740,200 $59.3M
14 Catalio Capital Management, LP 2.42% 144,607 $11.6M
15 Mirova US LLC 2.39% 2,627,315 $210.4M
16 Fulcrum Capital LLC 2.39% 137,336 $11.0M
17 Nantahala Capital Management, LLC 2.36% 800,000 $64.1M
18 Ninety One UK Ltd 2.30% 12,396,143 $992.7M
19 Ninety One North America, Inc. 2.29% 637,330 $51.0M
20 Orbimed Advisors LLC 1.95% 1,230,600 $98.5M
21 PFM Health Sciences, LP 1.86% 254,510 $20.4M
22 Rhenman & Partners Asset Management AB 1.61% 163,000 $13.1M
23 Nan Shan Life Insurance Co., Ltd. 1.60% 552,221 $44.2M
24 Bellevue Group AG 1.60% 839,451 $67.2M
25 Liontrust Investment Partners LLP 1.57% 1,244,381 $106.1M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Edwards Lifesciences Corp (EW)

What does the Smart Money Trend signal show for EW?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their EW positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for EW?

More sellers than buyers — 49% buying: Last quarter: 600 funds reduced or exited vs 586 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

What is the fund quality score for EW holders?

Elite ownership — 51% AUM from top-100 funds: 62 of 1279 holders are among the 100 largest funds by AUM, controlling 51% of total institutional value in EW. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held EW?

70% of holders stayed for 2+ years: 906 out of 1,286 hedge funds have held EW for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Edwards Lifesciences Corp (EW) following the 2026 Q1 hedge fund 13F filings?

As of today, EW has moved +6.0% since the 2026 Q1 13F filing date (May 15, 2026), compared to nan% for the XLV sector ETF — an outperformance of nan%. Since the quarter end (March 31, 2026), EW has gained +7.7% vs nan% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →